The authors declare that they have no competing interest.
VPJ was involved in the clinical diagnosis, management, literature survey and manuscript preparation. SB carried out the molecular genetic studies, literature search, data analysis and manuscript preparation. EM carried out the molecular genetic studies, literature search and data analysis. AS supervised the genetic studies, literature survey, data analysis, manuscript preparation and editing. All authors read and approved the final manuscript.
Insulinomas, which are rare tumors causing hyperinsulinemic hypoglycemia are usually sporadic but may also occur in association with multiple endocrine neoplasia type 1 (MEN-1) syndrome an autosomal dominant disorder caused by MEN1 gene mutations. MEN1 encodes a nuclear protein Menin, a tumor suppressor which acts as an adapter and interacts with partner proteins involved in crucial activities like transcriptional regulation, cell division, proliferation and genome stability.
This study reports on clinical findings and mutation screening in sporadic insulinoma patients.
Seventeen patients diagnosed with insulinoma were recruited along with 30 healthy volunteers who acted as controls for the present study. The patients presented with symptoms of sweating, tremors, drowsiness, palpitations, loss of consciousness, abnormal behavior, seizures and weight gain. Detailed clinical and family history was collected from all the participants along with 5 ml of blood sample after taking informed consent.
Genomic DNA isolated from blood was subjected to MEN1 gene amplification followed by direct sequencing. Nucleotide sequences obtained were compared with published MEN1 cDNA sequences. Prediction of functional effects of novel changes was done using various bioinformatics algorithms.
Molecular analysis revealed presence of three novel exonic mutations (M561K, Q192K and Q261Q), two novel intronic variations c.445-44G → A and c.913-42G → C in introns two and six respectively and three reported exon SNPs; H433H (rs540012), D418D (rs2071313), A541T (rs2959656) and one intronic SNP (rs669976).
The study identified presence of novel pathogenic MEN1 mutations in sporadic cases of insulinoma. The new mutations identified were in regions involved in defective binding of menin to proteins implicated in genetic and epigenetic mechanisms. The outcome of the study extends the growing list of MEN1 pathogenic mutations even in sporadic cases providing consequential insight into phenotypic heterogeneity and in the expression of individual mutations.
Abu-Zaid A, Alghuneim LA, Metawee MT, Elkabbani RO, Almana H, Amin T, et al. Sporadic insulinoma in a 10-year-old boy: a case report and literature review. JOP. 2014;15(1):53–7. PubMed
Jyotsna VP, Rangel N, Pal S, Seith A, Sahni P, Ammini AC. Insulinoma: Diagnosis and surgical treatment. Retrospective analysis of 31 cases. Indian J Gastroenterol. 2006;25(5):244–7. PubMed
Thakker RV, Bouloux P, Wooding C, Chotai K, Broad PM, Spurr NK, et al. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med 1989, 321(4):218–24. 15. Knudson AG: All in the (cancer) family. Nat Genet. 1993;5(2):103–4. CrossRef
Canaff L, Vanbellinghen JF, Kaji H, Goltzman D, Hendy GN. Impaired transforming growth factor-β (TGF-β) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1). J Biol Chem. 2012;287(11):8584–97. CrossRefPubMedPubMedCentral
Yaguchi H, Ohkura N, Tsukada T, Yamaguchi K. Menin the multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presenceof the tumor metastasis suppressor nm23. J Biol Chem. 2002;277(41):38197–204.
Shan L, Nakamura Y, Nakamura M, Yokoi T, Tsujimoto M, Arima R, et al. Somatic mutations of multiple endocrine neoplasia type 1 gene in the sporadic endocrine tumors. Lab Invest. 1998;78(4):471–5. PubMed
Nozieres C, Zhang CX, Buffet A, Dupasquier S, Vargas-Poussou R, Guillaud-Bataille M, et al. Groupe français des tumeurs endocrines (GTE): p.Ala541Thr variant of MEN1 gene: a non deleterious polymorphism or a pathogenic mutation? Ann Endocrinol. 2014;75(3):133–40. CrossRef
Drori-Herishanu L, Horvath A, Nesterova M, Patronas Y, Lodish M, Bimpaki E, et al. An Intronic mutation is associated with prolactinoma in a young boy, decreased penetrance in his large family, and variable effects on MEN1 mRNA and protein. Horm Metab Res. 2009;41(8):630–4. CrossRefPubMedPubMedCentral
- Novel MEN 1 gene findings in rare sporadic insulinoma—a case control study
Viveka P. Jyotsna
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II